Pre-eclampsia primary prevention: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| Line 8: | Line 8: | ||
<ref name="RolnikWright2017">{{cite journal|last1=Rolnik|first1=Daniel L.|last2=Wright|first2=David|last3=Poon|first3=Liona C.|last4=O’Gorman|first4=Neil|last5=Syngelaki|first5=Argyro|last6=de Paco Matallana|first6=Catalina|last7=Akolekar|first7=Ranjit|last8=Cicero|first8=Simona|last9=Janga|first9=Deepa|last10=Singh|first10=Mandeep|last11=Molina|first11=Francisca S.|last12=Persico|first12=Nicola|last13=Jani|first13=Jacques C.|last14=Plasencia|first14=Walter|last15=Papaioannou|first15=George|last16=Tenenbaum-Gavish|first16=Kinneret|last17=Meiri|first17=Hamutal|last18=Gizurarson|first18=Sveinbjorn|last19=Maclagan|first19=Kate|last20=Nicolaides|first20=Kypros H.|title=Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia|journal=New England Journal of Medicine|volume=377|issue=7|year=2017|pages=613–622|issn=0028-4793|doi=10.1056/NEJMoa1704559}}</ref><ref name="MayrinkCosta2018">{{cite journal|last1=Mayrink|first1=J.|last2=Costa|first2=M. L.|last3=Cecatti|first3=J. G.|title=Preeclampsia in 2018: Revisiting Concepts, Physiopathology, and Prediction|journal=The Scientific World Journal|volume=2018|year=2018|pages=1–9|issn=2356-6140|doi=10.1155/2018/6268276}}</ref> | <ref name="RolnikWright2017">{{cite journal|last1=Rolnik|first1=Daniel L.|last2=Wright|first2=David|last3=Poon|first3=Liona C.|last4=O’Gorman|first4=Neil|last5=Syngelaki|first5=Argyro|last6=de Paco Matallana|first6=Catalina|last7=Akolekar|first7=Ranjit|last8=Cicero|first8=Simona|last9=Janga|first9=Deepa|last10=Singh|first10=Mandeep|last11=Molina|first11=Francisca S.|last12=Persico|first12=Nicola|last13=Jani|first13=Jacques C.|last14=Plasencia|first14=Walter|last15=Papaioannou|first15=George|last16=Tenenbaum-Gavish|first16=Kinneret|last17=Meiri|first17=Hamutal|last18=Gizurarson|first18=Sveinbjorn|last19=Maclagan|first19=Kate|last20=Nicolaides|first20=Kypros H.|title=Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia|journal=New England Journal of Medicine|volume=377|issue=7|year=2017|pages=613–622|issn=0028-4793|doi=10.1056/NEJMoa1704559}}</ref><ref name="MayrinkCosta2018">{{cite journal|last1=Mayrink|first1=J.|last2=Costa|first2=M. L.|last3=Cecatti|first3=J. G.|title=Preeclampsia in 2018: Revisiting Concepts, Physiopathology, and Prediction|journal=The Scientific World Journal|volume=2018|year=2018|pages=1–9|issn=2356-6140|doi=10.1155/2018/6268276}}</ref> | ||
*In a recent clinical trial, there was 62% reduction in the occurrence of [[preeclampsia]] in patients received 150 mg aspirin daily. | *In a recent clinical trial, there was 62% reduction in the occurrence of [[preeclampsia]] in patients received 150 mg aspirin daily. | ||
* There is not strong evidence about the effectiveness of [[vitamin C]], [[vitamin E ]], [[folic acid]] , [[sodium restriction]] | * There is not strong evidence about the effectiveness of [[vitamin C]], [[vitamin E ]], [[folic acid]] , [[sodium restriction]] for prevention of [[preeclampsia]].<ref name="pmid18254042">{{cite journal |vauthors=Rumbold A, Duley L, Crowther CA, Haslam RR |title=Antioxidants for preventing pre-eclampsia |journal=Cochrane Database Syst Rev |volume= |issue=1 |pages=CD004227 |date=January 2008 |pmid=18254042 |pmc=6718237 |doi=10.1002/14651858.CD004227.pub3 |url=}}</ref><ref name="OstadrahimiMohammad-Alizadeh2016">{{cite journal|last1=Ostadrahimi|first1=Alireza|last2=Mohammad-Alizadeh|first2=Sakineh|last3=Mirgafourvand|first3=Mozhgan|last4=Yaghoubi|first4=Sina|last5=Shahrisa|first5=Elham|last6=Farshbaf-Khalili|first6=Azizeh|title=Effects of Fish Oil Supplementation on Gestational Diabetes Mellitus (GDM): A Systematic Review|journal=Iranian Red Crescent Medical Journal|volume=18|issue=11|year=2016|issn=2074-1804|doi=10.5812/ircmj.24690}}</ref> | ||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
Revision as of 11:41, 7 October 2020
|
Pre-eclampsia Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Pre-eclampsia primary prevention On the Web |
|
American Roentgen Ray Society Images of Pre-eclampsia primary prevention |
|
Risk calculators and risk factors for Pre-eclampsia primary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sara Zand, M.D.[2]
Primary prevention
- Effective measures for the primary prevention of preeclampsia include administration of low dose aspirin before the 16th week of pregnancy and calcium supplement.[1]
- In a recent clinical trial, there was 62% reduction in the occurrence of preeclampsia in patients received 150 mg aspirin daily.
- There is not strong evidence about the effectiveness of vitamin C, vitamin E , folic acid , sodium restriction for prevention of preeclampsia.[4][5]
References
- ↑ Hofmeyr, G Justus; Lawrie, Theresa A; Atallah, Álvaro N; Torloni, Maria Regina (2018). "Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems". Cochrane Database of Systematic Reviews. doi:10.1002/14651858.CD001059.pub5. ISSN 1465-1858.
- ↑ Rolnik, Daniel L.; Wright, David; Poon, Liona C.; O’Gorman, Neil; Syngelaki, Argyro; de Paco Matallana, Catalina; Akolekar, Ranjit; Cicero, Simona; Janga, Deepa; Singh, Mandeep; Molina, Francisca S.; Persico, Nicola; Jani, Jacques C.; Plasencia, Walter; Papaioannou, George; Tenenbaum-Gavish, Kinneret; Meiri, Hamutal; Gizurarson, Sveinbjorn; Maclagan, Kate; Nicolaides, Kypros H. (2017). "Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia". New England Journal of Medicine. 377 (7): 613–622. doi:10.1056/NEJMoa1704559. ISSN 0028-4793.
- ↑ Mayrink, J.; Costa, M. L.; Cecatti, J. G. (2018). "Preeclampsia in 2018: Revisiting Concepts, Physiopathology, and Prediction". The Scientific World Journal. 2018: 1–9. doi:10.1155/2018/6268276. ISSN 2356-6140.
- ↑ Rumbold A, Duley L, Crowther CA, Haslam RR (January 2008). "Antioxidants for preventing pre-eclampsia". Cochrane Database Syst Rev (1): CD004227. doi:10.1002/14651858.CD004227.pub3. PMC 6718237 Check
|pmc=value (help). PMID 18254042. - ↑ Ostadrahimi, Alireza; Mohammad-Alizadeh, Sakineh; Mirgafourvand, Mozhgan; Yaghoubi, Sina; Shahrisa, Elham; Farshbaf-Khalili, Azizeh (2016). "Effects of Fish Oil Supplementation on Gestational Diabetes Mellitus (GDM): A Systematic Review". Iranian Red Crescent Medical Journal. 18 (11). doi:10.5812/ircmj.24690. ISSN 2074-1804.